Read ISOPT’s publication on the Global Cancer Crisis.
Explore our review on the increasing burden, deepening inequality and effective prevention initiatives.
Explore our review on the increasing burden, deepening inequality and effective prevention initiatives.
We invite you to join the ISOPT community to receive free updates, newsletters, and information on upcoming events.
May 19 -21, 2026
Leon, France
To close its wonderful 60th anniversary year, IARC will offer you the opportunity to register for a major scientific conference that will take place over three days, from 19 to 21 May 2026. This conference will bring together experts from around the world and will be held at IARC and la Halle Tony Garnier.
Learn More
June 13-14, 2026
Hong Kong, China
Join leading experts from around the world for Cancer Prevention, Early Detection, and Treatments. Watch for details coming soon.
September 24-26, 2026
Hong Kong, China
World Cancer Congress 2026 will be organized in collaboration with the Hong Kong Anti-Cancer Society, a long-standing UICC member organization.
Learn More
Mission Statement: ISOPT unites the world in cancer prevention and early detection. Through free multilingual virtual education, we help equip physicians, nurses, genetic counselors, patient advocates, policymakers, and at-risk individuals with the knowledge to assess risk, implement prevention strategies, detect cancer early, and provide multidisciplinary care. Reaching globally across all six continents—we transform education into lives saved.
Charitable Contributions and Other Payments. The International Society of Prevention and Treatment USA Inc. (“ISOPT USA”) is a qualified public charity under Section 501(c)(3) of the US Internal Revenue Code. Your contributions and support of our events are considered a charitable donation to the extent permitted by law. Tax ID Number 39-5091295.
Contact us: info@isopt.health
ALRCaN presents “Reliable leukemia subtyping with machine learning and conformal prediction?” with Dr. Mariya Lysenkova Wiklander “Dear friends and colleagues, We look forward to seeing you every Friday at 9 …
Advances in immunotherapy have reshaped the treatment landscape for advanced gastroesophageal adenocarcinoma (GEA). The addition of PD-1 blockade to platinum-based chemotherapy has improved survival in patients with HER2-negative metastatic gastric …
ALRCaN presents “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS” with Dr. Valentín Ortiz-Maldonado. “Dear friends and colleagues, …
Shanise Pearce, Credibility Health Equity Advocate, Founder at The Advocate’s Table shared a post on LinkedIn: “When I was diagnosed with Triple Negative Breast Cancer, I entered the healthcare system …
Shayan Datta, Medical registrar at UCLH with interests in Cardiology, GIM, and clinical research shared a post on LinkedIn: “Pleased to share that our descriptive case series on immune checkpoint …
Mike Kinnaird, Content Producer at Cancer Can Do One Podcast, shared a post on LinkedIn: “A cancer rehab specialist in the UK. A physician in the US. A clinical systems thinker …